Despite community vaccination against coronavirus disease 2019 (COVID-19) and reduced mortality, there are still challenges in treatment options for the disease. Due to the …
Abstract Coronavirus virus disease 2019 (COVID-19) is a viral infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), actually considered as …
LP Santamaría, MD Uzquiano, EU Carro… - Drug Discovery …, 2022 - Elsevier
In the COVID-19 pandemic, drug repositioning has presented itself as an alternative to the time-consuming process of generating new drugs. This review describes a drug repurposing …
The spread of the monkeypox virus has surged during the unchecked COVID-19 epidemic. The most crucial target is the viral envelope protein, p37. However, lacking p37's crystal …
To date, mechanistic insights into many clinical drugs against COVID-19 remain unexplored. Dexamethasone, a corticosteroid, is one of them. While treating the entire corticosteroid …
Q Cheng, G Zhao, J Chen, Q Jia, Z Fang - Medicine, 2022 - journals.lww.com
Background: To date, there has been little agreement on what drug is the" best" drug for treating severe COVID-19 patients. This study aimed to assess the efficacy and safety of …
J Haneczok, M Delijewski - Journal of Biomedical Informatics, 2021 - Elsevier
Aim Rapidly developing AI and machine learning (ML) technologies can expedite therapeutic development and in the time of current pandemic their merits are particularly in …
G Kaur, N Singh, A Rajor, RK Arya - Environmental Science and Pollution …, 2023 - Springer
The huge demand and consumption of DOX, its incomplete metabolism, and complex behavior in atmosphere are causing a great ecological issue, which needs to be solved. In …
S Rani, A Garg, N Singh - Environmental Engineering Research, 2022 - eeer.org
Several drugs have sparked interest as potential COVID-19 treatment options. Doxycycline (DOX) has been widely used with other potential agents to reduce COVID-19-induced …